Quebec SEAO #AI-260410-PB

Procurement of Coroventis CoroFlow Cardiovascular System for Advanced Coronary Physiology Measurement

CISSS de la Montérégie-Est in Quebec is seeking to procure an advanced cardiovascular diagnostic system for its catheterization laboratories: - Government Buyer: - Centre intégré de santé et de services sociaux de la Montérégie-Est (CISSS de la Montérégie-Est), Quebec, Canada - OEM and Vendor: - Abbott Canada (OEM and sole-source vendor) - Product Requested: - Coroventis CoroFlow Cardiovascular System - Advanced diagnostic platform for measuring coronary physiology - Capabilities must include: - Index of Microcirculatory Resistance (IMR) - Coronary Flow Reserve (CFR) - Thermodilution and in situ pressure measurements - Absolute flow and resistance measurements by continuous thermodilution - Equipment must be new and certified to Quebec standards - Notable Requirements: - Sole-source procurement: Abbott Canada is the only vendor meeting all technical requirements - No specific quantity or part number provided - Contract duration: 36 months, with two one-year renewal options (up to 60 months total) - Place of Performance: - Centre intégré de santé et de services sociaux de la Montérégie-Est, Longueuil, Quebec, Canada

Description

The CISSS de la Montérégie-Est intends to acquire an Advanced Diagnostic Platform used in catheterization laboratories to measure Coronary Physiology. The equipment must be new and meet specific criteria including calculation of the Index of Microcirculatory Resistance (IMR), Coronary Flow Reserve (CFR), and measurements via thermodilution and in situ pressure. The contract is intended to be awarded to Abbott Canada for the Coroventis CoroFlow Cardiovascular System, the only equipment meeting all requirements. The contract duration is 36 months with two one-year renewal options, totaling up to 60 months.

View original listing